Metoprolol tartrate and Hypertonic bladder - a phase IV clinical study of FDA data

Summary:

Hypertonic bladder is reported as a side effect among people who take Metoprolol tartrate (metoprolol tartrate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Singulair, and have Breast cancer.

The phase IV clinical study analyzes which people have Hypertonic bladder when taking Metoprolol tartrate. It is created by eHealthMe based on reports of 83,460 people who have side effects when taking Metoprolol tartrate from the FDA, and is updated regularly.

What is Metoprolol tartrate?

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 89,747 Metoprolol tartrate users. Check the latest studies of Metoprolol tartrate.

What is Hypertonic bladder?

Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate) is found to be associated with 593 drugs and 520 conditions by eHealthMe. Check the latest studies of Hypertonic bladder.

On Jul, 07, 2026

83,460 people reported to have side effects when taking Metoprolol tartrate.
Among them, 28 people (0.03%) have Hypertonic bladder.

Could Metoprolol tartrate cause Hypertonic bladder?

Among these 28 people:

How long have people been on Metoprolol tartrate when they have Hypertonic bladder? *

What is the gender of people who have Hypertonic bladder when taking Metoprolol tartrate? *

female: 89.29 %
male: 10.71 %

What is the age of people who have Hypertonic bladder when taking Metoprolol tartrate? *

What are other drugs people take besides Metoprolol tartrate? *

What are other side effects people have besides Hypertonic bladder? *

Hypoaesthesia (reduced sense of touch or sensation): 16 people, 57.14%
Pain: 16 people, 57.14%
Urinary Tract Infection: 16 people, 57.14%
Joint Pain: 15 people, 53.57%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 15 people, 53.57%
Cardiac Failure Congestive: 15 people, 53.57%
Stress And Anxiety: 14 people, 50.00%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 14 people, 50.00%
Sleep Apnea Syndrome: 14 people, 50.00%
Nosebleed (bleeding from nose): 14 people, 50.00%

What are the existing conditions these people have? *

Breast Cancer: 3 people, 10.71%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 7.14%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 7.14%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 7.14%
Multiple Myeloma (cancer of the plasma cells): 2 people, 7.14%
Constipation: 2 people, 7.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.57%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 3.57%
Complications Of Transplanted Kidney: 1 person, 3.57%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol tartrate and have Hypertonic bladder?

- Check whether Hypertonic bladder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoprolol tartrate:

Metoprolol tartrate (89,747 reports)

Browse all side effects of Metoprolol tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertonic bladder:

Hypertonic bladder (593 drugs)

Browse all the conditions that are associated with Hypertonic bladder:

Hypertonic bladder (520 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Metoprolol tartrate) and Metoprolol tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.